Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT01168804

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Medical University Hospital Graz Graz, Austria
  • Hospital Elisabethinen Linz Linz, Austria
  • LKH Salzburg, 3rd Med. Dept. Salzburg, Austria
  • Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria
View Trial Details
Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mercy Medical Center Canton, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States
View Trial Details

Related conditions